Effects of simulated microgravity on colorectal cancer organoids growth and drug response

Soon-Chan Kim1,2,3, Min Jung Kim2,4,5, Ji Won Park2,4,5

  • 1Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, 103, Daehak-ro, Jongno-gu, Seoul, 03080, Korea.

Scientific Reports
|October 27, 2024
PubMed

Insights

Simulated microgravity alters colorectal cancer (CRC) cell behavior, increasing viability and proliferation. This environment enhances the effectiveness of 5-fluorouracil (5-FU) chemotherapy for CRC treatment.

Area of Science:

  • Space biology
  • Oncology
  • Genomics

Background:

  • Gravity influences human cell dynamics, but cancer cell responses to microgravity are not well understood.
  • Understanding these responses is crucial for potential space-based cancer research and treatment.

Purpose of the Study:

  • To investigate the transcriptomic and drug response profiles of colorectal cancer (CRC) organoids under simulated microgravity.
  • To identify molecular and physiological changes in CRC cells exposed to reduced gravitational forces.

Main Methods:

  • Established four patient-derived colorectal cancer organoids.
  • Utilized a 3D clinostat to simulate microgravity.
  • Performed genome-wide expression profiling and drug library screening.

Main Results:

  • Simulated microgravity increased CRC cell viability and altered cell morphology.
  • Transcriptomic analysis revealed significant dysregulation in the TBC1D3 gene family.
  • Enriched cell cycle processes indicated upregulated cell proliferation.
  • Enhanced response rates to 5-fluorouracil (5-FU) were observed under simulated microgravity.

Conclusions:

  • Simulated microgravity significantly impacts CRC cell behavior, promoting proliferation and altering gene expression.
  • The enhanced sensitivity to 5-FU suggests potential therapeutic strategies for colorectal cancer in microgravity environments.

Related Concept Videos